Journal
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY
Volume 12, Issue 1, Pages -Publisher
COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a036418
Keywords
-
Categories
Funding
- Concerted Research Actions (GOA) of the Ghent University
- Research Foundation -Flanders (FWO)
- Geneeskundige Stichting Koningin Elisabeth (GSKE)
- Charcot Foundation
- Belgian Foundation against Cancer
- Kom op tegen Kanker
- CBC Banque Prize
Ask authors/readers for more resources
A20 is a potent anti-inflammatory protein, acting by inhibiting nuclear factor kappa B (NF-kappa B) signaling and inflammatory gene expression and/or by preventing cell death. Mutations in the A20/TNFAIP3 gene have been associated with a plethora of inflammatory and autoimmune pathologies in humans and in mice. Although the anti-inflammatory role of A20 is well accepted, fundamental mechanistic questions regarding its mode of action remain unclear. Here, we review new findings that further clarify the molecular and cellular mechanisms by which A20 controls inflammatory signaling and cell death, and discuss new evidence for its involvement in inflammatory and autoimmune disease development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available